IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy.
Mazzarino
C
C
General Pathology Institute, University of Catania.
Nicosia
A
A
Monte
V
V
Petralia
S
S
Garraffo
C
C
Girlando
A
A
Santoro
S
S
Malaponte
G
G
D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008134:Long-Term Care; D015375:Receptors, Interleukin-2 / Q000097:blood*; D016305:Thymopentin / Q000494:pharmacology* / Q000627:therapeutic use
D015375:Receptors, Interleukin-2; D016305:Thymopentin